IGC
IGC Pharma, Inc.
0.27
200 x undefined
400 x 0.27
bid
ask
+
0.00
0.99%
300 @ 04:00 PM
0.27 +0.00 (0.00%)
| Ytd | -1.89% | |
| 1y | -8.43% |
0.27
day range
0.28
0.24
52 week range
0.50
| Open | 0.27 | Prev Close | 0.27 | Low | 0.27 | High | 0.28 | Mkt Cap | 27.50M |
| Vol | 219.00K | Avg Vol | 1.28M | EPS | -0.06 | P/E | N/A | Forward P/E | -3.74 |
| Beta | 1.29 | Short Ratio | 2.29 | Inst. Own | 22.00% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-11 | 50-d Avg | 0.30 | 200-d Avg | 0.32 | 1yr Est | 3.75 |
| Income Statement | |||
| Total Revenue | 317.00K | ||
| Revenues (USD) | 317.00K | ||
| Cost of Revenue | 262.00K | ||
| Gross Profit | 55.00K | ||
| Operating Expenses | 2.51M | ||
| Research and Development Expense | 1.27M | ||
| Selling, General and Administrative Expense | 1.24M | ||
| Operating Income | -2.46M | ||
| Net Income | -2.40M | ||
| Net Income Common Stock | -2.40M | ||
| Net Income Common Stock (USD) | -2.40M | ||
| Consolidated Income | -2.40M | ||
| Earnings per Basic Share | -0.02 | ||
| Earnings per Basic Share (USD) | -0.02 | ||
| Earnings per Diluted Share | -0.02 | ||
| Earning Before Interest & Taxes (EBIT) | -2.40M | ||
| Earning Before Interest & Taxes (USD) | -2.40M | ||
| Weighted Average Shares | 98.16M | ||
| Weighted Average Shares Diluted | 98.16M | ||
| Balance Sheet | |||
| Cash and Equivalents | 444.00K | ||
| Cash and Equivalents (USD) | 444.00K | ||
| Investments | 28.00K | ||
| Investments Current | 28.00K | ||
| Trade and Non-Trade Receivables | 37.00K | ||
| Current Assets | 1.15M | ||
| Property, Plant & Equipment Net | 2.11M | ||
| Total Assets | 9.19M | ||
| Debt Current | 726.00K | ||
| Total Debt | 917.00K | ||
| Current Liabilities | 2.87M | ||
| Debt Non-Current | 191.00K | ||
| Total Liabilities | 3.06M | ||
| Accumulated Retained Earnings (Deficit) | -127.29M | ||
| Accumulated Other Comprehensive Income | -5.71M | ||
| Shareholders Equity | 6.12M | ||
| Shareholders Equity (USD) | 6.12M | ||
| Assets Non-Current | 8.04M | ||
| Total Debt (USD) | 917.00K | ||
| Goodwill and Intangible Assets | 5.27M | ||
| Inventory | 638.00K | ||
| Liabilities Non-Current | 191.00K | ||
| Trade and Non-Trade Payables | 1.25M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 58.00K | ||
| Net Cash Flow from Financing | 710.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -693.00K | ||
| Capital Expenditure | -1000 | ||
| Issuance (Purchase) of Equity Shares | 87.00K | ||
| Issuance (Repayment) of Debt Securities | 623.00K | ||
| Net Cash Flow from Investing | -170.00K | ||
| Net Cash Flow from Operations | -1.22M | ||
| Effect of Exchange Rate Changes on Cash | -10.00K | ||
| Share Based Compensation | 1.01M | ||